October 1, 2021Open Access

Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study

Key points are not available for this paper at this time.

Combination of LEN, PD-1 and TACE showed a high rate of tumor response and convert resection in uHCC patients, with manageable toxicity.

Perguntar à IA

Bookmark

View Full Paper

Cite This Study

Wu et al. (Fri,) studied this question.

Perguntar à IA

Bookmark

View Full Paper